Optical spectral transmission, a novel noninvasive light-based technology, can effectively differentiate patients with inflammatory arthritis from healthy control individuals, a recent study showed.
Learn more about whether Fabrinet or Littelfuse, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Transfusions of red blood cells (RBCs) can be life-saving treatments for patients suffering from anemia, where the body lacks enough healthy RBCs to effectively deliver oxygen around the body. But the ...
Scientists have developed a high-resolution distributed temperature sensing technique using plastic optical fibers, achieving a spatial resolution of 4.8 centimeters. This breakthrough, based on ...
GAAP net income for the second quarter of fiscal year 2025 was $86.6 million, compared to $69.1 million for the second quarter of fiscal year 2024. GAAP net income per diluted share for the second ...
This company’s explosion-proof sensor (photo) combines near-infrared technology with robust safety features, providing accuracy and reliability in explosive atmospheres. This sensor offers protection ...